The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous – impact on Britain’s pharmacies and patients, writes Leyla Hannbeck, CEO of the Ind ...

FAT jab users are scrambling to buy Mounjaro before price hikes of more than 50 per cent. Pharmacies reported an influx of ...

Steroid dealers using social media and beauty salons to sell cheap Chinese copies of weight-loss drugs, experts warn ...

With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations ...

New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs ...

A pioneering new food supplement that costs just £49 per week could be even more effective than Ozempic, experts have claimed ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...